Work

O7-3 Pembrolizumab vs chemotherapy in MSI-H / dMMR metastatic colorectal cancer: KEYNOTE-177 final analysis Asia subgroup

Year: 2022

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2022.05.030

Authors: Takayuki Yoshino, Thierry André, Kai-Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelius J.A. Punt, Denis Smith, Rocio Garcia-Carbonero, Peter Gibbs, T. Le Dung, Noriaki Adachi, David Fogelman, Patricia Marinello, Luis A. Diaz

Institutions: National Cancer Center Hospital East, Hôpital Saint-Antoine, University College Hospital, University College London Hospitals NHS Foundation Trust, Asan Medical Center, Herlev Hospital, Gentofte Hospital, Vejle Sygehus, Amsterdam University Medical Centers, University of Amsterdam, Hôpital Cardiologique du Haut-Lévêque, Hospital Universitario 12 De Octubre, Western Hospital, Sidney Kimmel Comprehensive Cancer Center, MSD K.K. (Japan), Merck & Co., Inc., Rahway, NJ, USA (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4286265336

FWCI: 0.091

Cites:

Cited by: 1

Related to: 10